For the first time, a randomized study demonstrates that a 15-day empirical treatment with valganciclovir can reduce mortality in infants living with HIV hospitalized for severe pneumonia in Africa.
For the first time, a randomized study demonstrates that a 15-day empirical treatment with valganciclovir can reduce mortality in infants living with HIV hospitalized for severe pneumonia in Africa.